Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence

• Wei Pan,
• Diao Yu,
• Na Shi,
• Zheng Bao

Affiliations

Wei Pan

Department of Clinical Laboratory, Haiyan People’s Hospital, Haiyan, Zhejiang, China

Diao Yu

Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, China

Na Shi

Department of Clinical Laboratory, Second Sanatorium of Air Force Healthcare Center for Special Services, Hangzhou, Zhejiang, China

Zheng Bao

Department of Clinical Laboratory, Xiangshan Red Cross Taiwan Compatriot Hospital, Xiangshan, Zhejiang, China